Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)

NCT00109031 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Lymphoma
Leukemia

Interventions

DRUG: palifermin
RADIATION: Total Body Irradiation
DRUG: Cyclophosphamide
DRUG: Etoposide
DRUG: Placebo

Sponsor

Swedish Orphan Biovitrum

Collaborators

[object Object]